Abstract
Hypoxia-inducible factor 1 alpha (HIF-1α) is closely related to chemoresistance of ovarian cancers. Although it is reported that HIF-1α can be regulated by Sentrin/SUMO-specific protease 1 (SENP1), the effects of SENP1 on HIF-1α is still controversial. In this study, we identified that SENP1 positively regulated the expression of HIF-1α by deSUMOylation and weakened the sensitivity of hypoxic ovarian cancer cells to cisplatin. These results indicate that SENP1 is a positive regulator of HIF-1α and plays a negative role in ovarian cancer chemotherapy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Cell Hypoxia
-
Cell Line, Tumor
-
Cisplatin / pharmacology*
-
Cysteine Endopeptidases
-
Drug Resistance, Neoplasm* / genetics
-
Endopeptidases / genetics*
-
Endopeptidases / metabolism
-
Female
-
Gene Expression Regulation, Neoplastic / drug effects*
-
Humans
-
Hypoxia-Inducible Factor 1, alpha Subunit / genetics*
-
Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
-
Ovarian Neoplasms / genetics*
-
Ovarian Neoplasms / metabolism
-
Sumoylation
Substances
-
Antineoplastic Agents
-
Hypoxia-Inducible Factor 1, alpha Subunit
-
Endopeptidases
-
SENP1 protein, human
-
Cysteine Endopeptidases
-
Cisplatin